Roche Buys Constitution Medical for $220 Million

Roche Holding AG (ROG) said it bought Constitution Medical Investors Inc., a U.S. blood-testing company, for $220 million plus payments related to development of products.

CMI, based in Boston, Massachusetts and created and funded by private-equity company Warburg Pincus and CMI’s management, will serve as a ’’center of excellence’’ in the field of hematology within Roche’s diagnostics unit, the Basel, Switzerland-based company said today in a statement.

CMI makes the Bloodhound system, a product that tests blood samples for diseases that’s fully automated and replaces several work stations with a single unit. Roche said the blood-testing market was worth more than $2 billion in 2011.

To contact the reporter on this story: Thomas Mulier in Geneva at

To contact the editor responsible for this story: David Risser at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.